The Incidence of Post-Transplant Malignancies in Kidney Transplant Recipients Treated with Rituximab. Bachelet T, Visentin J, Davis P, Taton B, et al. Clin Transplant 2020 Nov 28:e14171. doi: 10.1111/ctr.14171.

Read + Share

Amedeo Smart

Independent Medical Education

Bachelet T, Visentin J, Davis P, Taton B, et al. The Incidence of Post-Transplant Malignancies in Kidney Transplant Recipients Treated with Rituximab. Clin Transplant 2020 Nov 28:e14171. doi: 10.1111/ctr.14171.
PMID: 33247459